Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
R&Q Insurance Holdings Ltd. (RQIHF)
Hamilton, BM
R&Q Insurance Holdings Ltd. is a specialized non-life insurance enterprise primarily active across the United States and Europe. The company focuses on purchasing books of non-life business that are no longer actively underwriting new policies, as well as acquiring non-life insurance firms and captive insurers that are in run-off. It offers a range of exit and restructuring solutions for insurance operations, which include direct acquisitions, transferring portfolios, engaging in reinsurance, facilitating insurance business transfers, and providing policies for self-insured retentions (SIR) or deductible reimbursements. Additionally, R&Q delivers program management services. The company also serves as an intermediary, connecting Managing General Agents (MGAs) and other niche underwriters with appropriate capital providers. Founded in 1991, and headquartered in Hamilton, Bermuda, the organization adopted its current name, R&Q Insurance Holdings Ltd., in July 2022, having previously been known as Randall & Quilter Investment Holdings Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | -100.00% | -100.00% | -100.00% | -100.00% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Insurance - Specialty: +11.0%-24.1% Q2'23: +322.3% (vs Q2'21)
-
EPS growth Insurance - Specialty: +18.3%-93.6% Q2'23: -124.1% (vs Q2'21)
-
FCF margin FCF growth · Insurance - Specialty: +39.7%+94.1% Q2'23: -72.9% (vs Q2'21)
-
EBIT margin Insurance - Specialty: +18.3%-323.2% Q2'23: -39.6% (vs Q2'21)
-
ROIC Insurance - Specialty: +10.3%-118.9% Q2'23: -77.4% (vs Q2'21)
-
Share dilution Insurance - Specialty: +0.5%+19.8% Q2'23: +77.6% (vs Q2'21)
-
Debt / EBITDA Net debt/EBITDA · Insurance - Specialty: 0.25×-1.41× Q2'23: -1.12× (vs Q2'21)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
98.03M
est: 104.07M (-5.8%)
|
74.61M
est: 91.19M (-18.2%)
|
250.38M
est: 228.89M (+9.4%)
|
102.92M
est: 326.04M (-68.4%)
|
341.96M
est: 290.12M (+17.9%)
|
521.00M
est: 534.17M (-2.5%)
|
106.30M
est: 975.73M (-89.1%)
|
80.70M
est: 1.72B (-95.3%)
|
2.75B
est.
|
3.12B
est.
|
| EBITDA |
9.45M
est: -31.36M (+130.1%)
|
15.17M
est: -27.48M (+155.2%)
|
30.57M
est: -68.97M (+144.3%)
|
22.20M
est: -98.25M (+122.6%)
|
77.41M
est: -87.43M (+188.5%)
|
68.70M
est: -160.97M (+142.7%)
|
-119.60M
est: -294.04M (+59.3%)
|
-248.70M
est: -519.72M (+52.1%)
|
-827.91M
est.
|
-889.28M
est.
|
| EBIT |
6.31M
est: -33.07M (+119.1%)
|
10.44M
est: -28.98M (+136.0%)
|
19.31M
est: -72.73M (+126.6%)
|
23.94M
est: -103.60M (+123.1%)
|
62.69M
est: -92.19M (+168.0%)
|
51.50M
est: -169.74M (+130.3%)
|
-135.30M
est: -310.05M (+56.4%)
|
-260.80M
est: -548.02M (+52.4%)
|
-873.01M
est.
|
-941.65M
est.
|
| Net Income |
4.42M
est: -32.66M (+113.5%)
|
10.38M
est: 27.05M (-61.6%)
|
30.97M
est: 58.48M (-47.1%)
|
12.51M
est: 27.19M (-54.0%)
|
48.90M
est: 59.87M (-18.3%)
|
37.80M
est: 43.76M (-13.6%)
|
-127.10M
est: -1.23M (-10,200.7%)
|
-297.00M
est: -25.33M (-1,072.4%)
|
20.70M
est.
|
44.35M
est.
|
| SGA |
116.58M
|
69.13M
|
113.97M
|
98.54M
|
113.78M
|
143.40M
|
166.00M
|
178.90M
est: 764.65M (-76.6%)
|
1.22B
est.
|
3.33B
est.
|
| EPS |
0.09
est: -0.10 (+186.3%)
|
0.17
est: 0.08 (+104.4%)
|
0.44
est: 0.18 (+144.7%)
|
0.09
est: 0.08 (+13.3%)
|
0.35
est: 0.18 (+90.1%)
|
0.18
est: 0.13 (+33.8%)
|
-0.47
est: 0.00 (-12,288.7%)
|
-0.91
est: -0.08 (-1,068.4%)
|
0.06
est.
|
0.14
est.
|
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Carrie Hewitt | Group Chief Actuary & Head of Capital Management | — | female |
| Chris Riseborough | EVice President of Legacy UK, Europe & Cayman | — | male |
| Huw Battrick | Global Head of M&A | — | male |
| Parri Spector | EVice President of Legacy North America & Bermuda | — | male |
| Susan Young | Chief Risk Officer | — | female |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RQIHF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
